Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03935633
What this trial is testing

Short-term Clinical Study of CN128 in Thalassemia Patients

Who this might be right for
Thalassemia
Hangzhou Zede Pharma-Tech Co., Ltd. 16
Large-scale testing (Phase 3)Study completedNCT04074187
What this trial is testing

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Sanofi 21
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Not applicableStudy completedNCT03106324
What this trial is testing

A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

Who this might be right for
Multiple Myeloma
Celgene 911
Large-scale testing (Phase 3)Ended earlyNCT02962388
What this trial is testing

The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line

Who this might be right for
Essential Thrombocythemia
French Innovative Leukemia Organisation 13
Testing effectiveness (Phase 2)Study completedNCT00739388
What this trial is testing

Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy

Who this might be right for
Leukemia
Swiss Cancer Institute 47
Large-scale testing (Phase 3)Ended earlyNCT00176839
What this trial is testing

Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Leukemia, Lymphocytic, AcuteAMLMDS
Masonic Cancer Center, University of Minnesota 11
Testing effectiveness (Phase 2)Study completedNCT01246557
What this trial is testing

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Who this might be right for
Chronic Lymphatic Leukemia
Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00147901
What this trial is testing

Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
German CLL Study Group 61
Early research (Phase 1)Study completedNCT00545519
What this trial is testing

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Who this might be right for
Relapsed Or Refractory Multiple Myeloma
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT05115630
What this trial is testing

Off-the-shelf NK Cells + SCT for Myeloid Malignancies

Who this might be right for
Myeloid MalignanciesAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 24
Not applicableUnknownNCT05758207
What this trial is testing

Oral Complications in Hematological Malignancies

Who this might be right for
Hematologic Malignancy
Assiut University 100
Early research (Phase 1)Study completedNCT00001399
What this trial is testing

Gene Therapy for the Treatment of Fanconi's Anemia Type C

Who this might be right for
Fanconi's AnemiaPancytopenia
National Heart, Lung, and Blood Institute (NHLBI) 9
Testing effectiveness (Phase 2)UnknownNCT01735604
What this trial is testing

Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 50
Not applicableStudy completedNCT01940484
What this trial is testing

An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis

Who this might be right for
Anemia
Hoffmann-La Roche 98
Testing effectiveness (Phase 2)Study completedNCT04182100
What this trial is testing

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Who this might be right for
Polycythemia Vera (PV)
PharmaEssentia Japan K.K. 29
Not applicableStudy completedNCT01318707
What this trial is testing

Biomarkers Serum Collection Methodology Pilot Study

Who this might be right for
Hemophilia A
Georgetown University 20
Large-scale testing (Phase 3)Study completedNCT00495287
What this trial is testing

A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
Northern Italy Leukemia Group 573
Not applicableStudy completedNCT01090206
What this trial is testing

Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia

Who this might be right for
Hemophilia AHemophilia BVitamin D Deficiency
Virginia Commonwealth University 20
Testing effectiveness (Phase 2)Study completedNCT00014495
What this trial is testing

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center 32
Next Page